SageView Advisory Group’s Chemours CC Stock Holding History

SageView Advisory Group’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-140	Closed	-$1.65K	–	883
2025 Q4	$1.65K	Buy	+140	New	+$1.8K	﹤0.01%	2280

Other funds holding CC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

WHCM

Wolf Hill Capital Management Greenwich, Connecticut $1.2B AUM 137.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

SageView Advisory Group's CC Position: Q1 2026 in Review

SageView Advisory Group sold out of Chemours (CC) in Q1 2026, closing a stake of 140 shares — an estimated $1.65K sold.

SageView Advisory Group first reported a position in CC in Q4 2025 and held it in 1 quarter. The position peaked at $1.65K in Q4 2025. 450 funds tracked by Wall St. Rank hold CC as of Q1 2026.

SageView Advisory Group reported no remaining Chemours position as of Q1 2026 after selling out during the quarter.
SageView Advisory Group sold 140 Chemours shares in Q1 2026, an estimated $1.65K.
SageView Advisory Group first reported a position in Chemours in Q4 2025 and held it in 1 quarter.
SageView Advisory Group's Chemours position peaked at $1.65K in Q4 2025.
450 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on SageView Advisory Group's 13F filing for Q1 2026, filed 10 Aug 2026.